Atlas Trials

Pilot Study of Reduced-Intensity Hematopoietic Stem Cell Transplant of DOCK8 Deficiency

Clinical trial NCT01176006 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01176006
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
DOCK8 Deficiency
Start date
2010-10-05
Primary completion
2026-10-31
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.